Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (531-540 of 583) with videos related to

Pageof 59
Sort By:
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Leukemia|September 4, 2021
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Nature Genetics|February 2, 2000
Aberrant CpG-island methylation has non-random and tumour-type-specific patternsJ F Costello, M C Frühwald, D J Smiraglia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remissionSherif S Farag, Kati Maharry, Mei-Jie Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B studyKlaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Blood|August 23, 2021
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13Costanza Zanetti, Rahul Kumar, Joscha Ender, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
Pageof 59

Showing results (531-540 of 583) with videos related to

Sort By:
Pageof 59
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Leukemia|September 4, 2021
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Nature Genetics|February 2, 2000
Aberrant CpG-island methylation has non-random and tumour-type-specific patternsJ F Costello, M C Frühwald, D J Smiraglia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remissionSherif S Farag, Kati Maharry, Mei-Jie Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B studyKlaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Blood|August 23, 2021
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13Costanza Zanetti, Rahul Kumar, Joscha Ender, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
Pageof 59